142 related articles for article (PubMed ID: 3551602)
1. Comparison of nifedipine and propranolol used in combination with diuretics for the treatment of hypertension.
Zusman R; Christensen D; Federman E; Kochar MS; McCarron D; Porush JG; Spitalewitz S
Am J Med; 1987 Mar; 82(3B):37-41. PubMed ID: 3551602
[TBL] [Abstract][Full Text] [Related]
2. Comparison of blood pressure, plasma lipid and cardiac performance responses to prazosin versus propranolol in thiazide-treated hypertensive patients.
Misson R; Merkel T; Cutler RE
Am J Cardiol; 1984 Jan; 53(3):51A-54A. PubMed ID: 6364760
[TBL] [Abstract][Full Text] [Related]
3. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
Sacks FM; Creager MA; Gallagher SJ; Loscalzo J; Dzau VJ
Am J Med; 1989 Jan; 86(1B):8-13. PubMed ID: 2563311
[TBL] [Abstract][Full Text] [Related]
4. Multicenter comparison of the nifedipine gastrointestinal therapeutic system and long-acting propranolol in patients with mild to moderate systemic hypertension receiving diuretics. A preliminary experience.
Frishman WH; Garofalo JL; Rothschild A; Rothschild M; Greenberg SM; Soberman J
Am J Med; 1987 Dec; 83(6B):15-9. PubMed ID: 3332574
[TBL] [Abstract][Full Text] [Related]
5. Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial.
Goto Y
Am J Med; 1984 Feb; 76(2A):72-8. PubMed ID: 6142645
[TBL] [Abstract][Full Text] [Related]
6. Effect of nifedipine and propranolol on blood flow, venous compliance and blood pressure in essential hypertension.
Ogilvie RI
Can Med Assoc J; 1985 May; 132(10):1137-41. PubMed ID: 3995432
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine tablet vs. hydralazine in patients with persisting hypertension who receive combined diuretic and beta-blocker therapy.
Myers MG; Leenen FH; Burns R; Frankel D
Clin Pharmacol Ther; 1986 Apr; 39(4):409-13. PubMed ID: 2869849
[TBL] [Abstract][Full Text] [Related]
8. Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S77-81. PubMed ID: 2580181
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
[TBL] [Abstract][Full Text] [Related]
10. Nifedipine, but not propranolol, improves left ventricular systolic and diastolic function in patients with hypertension.
Zusman RM; Christensen DM; Federman EB; Ruddy TD; Miller DD; Boucher CA
Am J Cardiol; 1989 Sep; 64(11):51F-61F. PubMed ID: 2782271
[TBL] [Abstract][Full Text] [Related]
11. Comparison of ketanserin and slow-release nifedipine added to the treatment of hypertensive patients uncontrolled by a thiazide diuretic plus beta-adrenoceptor blocker.
Waller PC; Solomon SA; Ramsay LE
Br J Clin Pharmacol; 1987 Nov; 24(5):591-7. PubMed ID: 2893636
[TBL] [Abstract][Full Text] [Related]
12. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
Daniels AR; Opie LH
Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
[TBL] [Abstract][Full Text] [Related]
13. Hypotensive action of nifedipine (Ca2+-antagonist) and propranolol in acute trials and its long-term therapy of hypertensive coronary heart disease patients.
Aoki K; Kondo S; Sato K; Kato K; Kawaguchi Y; Mochizuki A; Yamamoto M
Jpn Heart J; 1981 Jul; 22(4):575-84. PubMed ID: 7300028
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure and heart rate in patients with ischaemic heart disease receiving nifedipine and propranolol.
Harris L; Dargie HJ; Lynch PG; Bulpitt CJ; Krikler DM
Br Med J (Clin Res Ed); 1982 Apr; 284(6323):1148-51. PubMed ID: 6803871
[TBL] [Abstract][Full Text] [Related]
15. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo-controlled, crossover trial to investigate the additive hypotensive effect of a diuretic (mefruside) to that produced by nifedipine.
Poulter N; Thompson AV; Sever PS
J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S53-6. PubMed ID: 2455140
[TBL] [Abstract][Full Text] [Related]
17. Comparison of nifedipine and captopril as third-line agents in hypertensive patients uncontrolled with beta-blocker and diuretic therapy.
Potter JF; Beevers DG
J Clin Pharmacol; 1987; 27(5):410-4. PubMed ID: 2891731
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of combined nifedipine and propranolol treatment in hypertension.
Yagil Y; Kobrin I; Stessman J; Ghanem J; Leibel B; Ben-Ishay D
Hypertension; 1983; 5(4 Pt 2):II113-7. PubMed ID: 6862585
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of prazosin versus propranolol on plasma lipoprotein lipids in patients receiving hemodialysis.
Harter HR; Meltzer VN; Tindira CA; Naumovich AD; Goldberg AP
Am J Med; 1986 Feb; 80(2A):82-9. PubMed ID: 3511693
[TBL] [Abstract][Full Text] [Related]
20. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
Zanchetti A
Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
